Chemical Structure : BMS-754807
CAS No.: 1001350-96-4
货号: PC-42444Not For Human Use, Lab Use Only.
BMS-754807 (BMS 754807, BMS754807) is a potent, reversible, orally active inhibitor of IGF-1R/Insulin receptor with IC50 of 1.8 and 1.7 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg (Free Sample) | ¥280 | In stock | |
10 mg | ¥1480 | In stock | |
25 mg | ¥2780 | In stock | |
50 mg | ¥4780 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BMS-754807 (BMS754807) is a potent, reversible, orally active inhibitor of IGF-1R/Insulin receptor with IC50 of 1.8 and 1.7 nM, respectively.
BMS-754807 shows additional off-target activities Met, RON, TrkA, TrkB, AurA, and AurB (IC50=5-45 nM) in a panel of 27 kinases.
BMS-754807 inhibits the growth of a broad range of human tumor types in vitro (IC50=5-365 nM), induces PARP and Caspase 3 cleavage, promotes apoptosis.
BMS-754807 exhibits tumor growth inhibition in xenograft tumor models.
分子量 | 461.4948 | |
分子式 | C23H24FN9O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-Pyrrolidinecarboxamide, 1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-, (2S)- |
1. Wittman MD, et al. Mol Cancer Ther. 2009 Dec;8(12):3341-9.
2. Carboni JM, et al. Mol Cancer Ther. 2009 Dec;8(12):3341-9.
3. Dinchuk JE, et al. Endocrinology. 2010 Sep;151(9):4123-32.
4. Huang F, et al. Cancer Res. 2010 Sep 15;70(18):7221-31.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright